SCORE

52

OXFD: OXFORD IMMUNOTEC GLOBAL is a Buy


The current rating for OXFD is 52, which is 4% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.